Prenatal Programming of Neonatal Asthma Susceptibility
新生儿哮喘易感性的产前规划
基本信息
- 批准号:7750741
- 负责人:
- 金额:$ 35.57万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2009
- 资助国家:美国
- 起止时间:2009-07-14 至 2014-03-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdoptive TransferAir PollutionAsthmaCell physiologyChemicalsCorticosteroneDNA MethylationDataDendritic CellsDermatitisDevelopmentDexamethasoneEnvironmental ExposureEpidemiologyEpigenetic ProcessEtiologyExposure toExtrinsic asthmaGene ExpressionGenesGlucocorticoidsHormonalHormonesHumanHypersensitivityITGAX geneImmune System DiseasesImmune responseImmunophenotypingInflammationLeadLifeLinkMaternal ExposureMeasuresMediatingModelingModificationMolecular ProfilingMothersMusNeonatalPathway interactionsPhenotypePhysiologyPlacentaPredispositionPregnancyProtocols documentationPublic HealthResearchRiskRisk FactorsRoleSkinSmall Interfering RNAStressTestingTherapeutic InterventionTobacco Smoke Pollutionallergic airway diseaseallergic airway inflammationbiological adaptation to stressbisulfiteenvironmental agentenvironmental stressorgene therapygenome wide association studygenome-widegenome-wide analysisinterestmaternal stressneonatenoveloffspringoverexpressionpregnantprenatalprogramspublic health relevancepupresearch studyresponse
项目摘要
DESCRIPTION (provided by applicant): Asthma begins in early life, and is linked to immune dysfunction that skews responses towards allergy. Human epidemiology identifies 'prenatal programming' for asthma susceptibility through the risk factor of maternal asthma. Our pilot data in maternal allergy reveal that the neonatal dendritic cell (DC) is the critical cellular agent of asthma susceptibility, since adoptive transfer of DCs from asthma- susceptible juvenile mice causes new asthma risk in otherwise normal pups. Genome-wide analysis of DNA methylation shows substantial differences in 'asthma-susceptible' DCs compared to controls. In addition to maternal asthma, other environmental exposures (e.g. tobacco smoke, air pollution) cause neonatal asthma risk, but mechanisms remain poorly characterized. Our experimental studies in normal mother mice show that various 'environmental stressors' all result in babies that are more susceptible to developing allergic airway disease. Our central hypothesis is that multiple environmental stressors cause early life asthma susceptibility through epigenetic modifications in neonatal DCs, which confer pro-asthmatic skewing of immune responses. Specific Aims: Aim 1 will use adoptive transfer of DCs to test the postulate that multiple maternal exposures (air pollution, chemical dermatitis, stress) all produce an altered 'asthma-susceptible' DC, similar to that observed in offspring of mothers with OVA-induced allergic asthma. DC subpopulations will be further characterized to optimize epigenetic analyses. Aim 2 will use genome-wide and targeted epigenetic analysis to test the prediction that 'asthma-susceptible' DCs will share epigenetic marks linked to skewing towards a pro- asthmatic DC phenotype. Aim 3 will test the hypothesis that the shared mechanism for myriad maternal 'environmental stressors' is a transplacental stress hormone response which causes the epigenetic and functional changes seen in 'asthma-susceptible' neonatal DCs Impact & Significance: The planned studies will identify how multiple environmental exposures of pregnant mothers cause asthma risk, and will provide targets for public health and therapeutic interventions. PUBLIC HEALTH RELEVANCE: The planned studies will identify how multiple environmental exposures of pregnant mothers cause asthma risk, and will provide targets for public health and therapeutic interventions.
描述(申请人提供):哮喘开始于生命早期,与免疫功能障碍有关,免疫功能障碍使过敏反应偏向。人类流行病学通过母亲哮喘的危险因素确定了哮喘易感性的“产前规划”。我们在母体过敏方面的初步数据显示,新生儿树突状细胞(DC)是哮喘易感性的关键细胞因子,因为过继转移哮喘易感幼鼠的DC会在其他正常的幼鼠中产生新的哮喘风险。全基因组DNA甲基化分析显示,与对照组相比,易感哮喘的树突状细胞存在显著差异。除母亲哮喘外,其他环境暴露(如烟草烟雾、空气污染)会导致新生儿哮喘风险,但机制仍不明确。我们在正常母鼠身上进行的实验研究表明,各种“环境应激源”都会导致婴儿更容易患上过敏性呼吸道疾病。我们的中心假设是,多种环境应激源通过新生儿树突状细胞的表观遗传修饰导致早期哮喘易感性,从而导致免疫反应的亲哮喘倾斜。具体目标:Aim 1将使用树突状细胞的收养转移来测试这样的假设,即母亲多次暴露(空气污染、化学性皮炎、压力)都会产生一种改变的“哮喘易感”DC,类似于在患有OVA诱导的过敏性哮喘的母亲的后代中观察到的情况。DC亚群将进一步表征,以优化表观遗传分析。AIM 2将使用全基因组和有针对性的表观遗传学分析来验证这样的预测,即“哮喘易感”DC将分享与偏向哮喘前期DC表型有关的表观遗传标记。目的3将检验这样一个假设,即众多母亲的环境应激源的共同机制是一种经胎盘的应激激素反应,该应激激素反应导致了易哮喘的新生儿DC的表观遗传学和功能变化&意义:计划中的研究将确定孕妇的多种环境暴露如何导致哮喘风险,并将为公共卫生和治疗干预提供靶点。公共卫生相关性:计划中的研究将确定孕妇暴露在多种环境中是如何导致哮喘风险的,并将为公共卫生和治疗干预提供目标。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
LESTER KOBZIK其他文献
LESTER KOBZIK的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('LESTER KOBZIK', 18)}}的其他基金
Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia
血浆凝溶胶蛋白作为抗生素耐药性肺炎的免疫治疗剂
- 批准号:
9146035 - 财政年份:2016
- 资助金额:
$ 35.57万 - 项目类别:
Plasma Gelsolin as Immunotherapeutic for Antibiotic-Resistant Pneumonia
血浆凝溶胶蛋白作为抗生素耐药性肺炎的免疫治疗剂
- 批准号:
9275351 - 财政年份:2016
- 资助金额:
$ 35.57万 - 项目类别:
2014 Biology of Acute Respiratory Infection Gordon Research Conference and Semina
2014年急性呼吸道感染生物学戈登研究会议及研讨会
- 批准号:
8650427 - 财政年份:2014
- 资助金额:
$ 35.57万 - 项目类别:
Transgenerational Susceptibility to Asthma from Air Pollution Exposure
空气污染暴露对哮喘的跨代易感性
- 批准号:
8598612 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
Plasma Gelsolin and Host Defense After Lung Injury
肺损伤后血浆凝溶胶蛋白和宿主防御
- 批准号:
8446681 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
Plasma Gelsolin and Host Defense After Lung Injury
肺损伤后血浆凝溶胶蛋白和宿主防御
- 批准号:
8989922 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
Transgenerational Susceptibility to Asthma from Air Pollution Exposure
空气污染暴露对哮喘的跨代易感性
- 批准号:
8728858 - 财政年份:2013
- 资助金额:
$ 35.57万 - 项目类别:
RNAi Screen in Air Pollutant-Enhanced Influenza Infection
RNAi 筛查空气污染物增强型流感感染
- 批准号:
8272707 - 财政年份:2011
- 资助金额:
$ 35.57万 - 项目类别:
RNAi Screen in Air Pollutant-Enhanced Influenza Infection
RNAi 筛查空气污染物增强型流感感染
- 批准号:
8130454 - 财政年份:2011
- 资助金额:
$ 35.57万 - 项目类别:
相似海外基金
Time to ATTAC: Adoptive Transfer of T cells Against gp100+ Cells to treat LAM
ATTAC 时间:针对 gp100 细胞的 T 细胞过继转移来治疗 LAM
- 批准号:
10682121 - 财政年份:2023
- 资助金额:
$ 35.57万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10576370 - 财政年份:2022
- 资助金额:
$ 35.57万 - 项目类别:
Phase I clinical trial of adoptive transfer of autologous folate receptor-alpha redirected CAR T cells for ovarian cancer
自体叶酸受体-α重定向CAR T细胞过继转移治疗卵巢癌的I期临床试验
- 批准号:
10387023 - 财政年份:2022
- 资助金额:
$ 35.57万 - 项目类别:
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10248409 - 财政年份:2019
- 资助金额:
$ 35.57万 - 项目类别:
A phase I clinical study of adoptive transfer of regulatory T cells (Tregs) and low-dose interleukin-2 (IL-2) for the treatment of chronic graft-versus-host disease (GVHD): gene-marking to inform rational combination therapy
调节性 T 细胞 (Treg) 和低剂量白细胞介素 2 (IL-2) 过继转移治疗慢性移植物抗宿主病 (GVHD) 的 I 期临床研究:基因标记为合理的联合治疗提供信息
- 批准号:
nhmrc : GNT1163111 - 财政年份:2019
- 资助金额:
$ 35.57万 - 项目类别:
Project Grants
Determining mechanisms of enhanced antitumor efficacy of four-day expanded Th17 cells for adoptive transfer
确定用于过继转移的四天扩增 Th17 细胞增强抗肿瘤功效的机制
- 批准号:
10462684 - 财政年份:2019
- 资助金额:
$ 35.57万 - 项目类别:
Gene edited lymphoid progenitors for adoptive transfer as a treatment of primary immunodeficiency
基因编辑的淋巴祖细胞用于过继转移作为原发性免疫缺陷的治疗
- 批准号:
398018062 - 财政年份:2018
- 资助金额:
$ 35.57万 - 项目类别:
Research Grants
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9308643 - 财政年份:2017
- 资助金额:
$ 35.57万 - 项目类别:
Overcoming immune suppression in cancer by targeting PSGL-1 in T cells used for adoptive transfer
通过靶向用于过继转移的 T 细胞中的 PSGL-1 克服癌症中的免疫抑制
- 批准号:
9447149 - 财政年份:2017
- 资助金额:
$ 35.57万 - 项目类别:
Targeting Cancer miRNAs by Adoptive Transfer of Programmed B Lymphocytes
通过程序化 B 淋巴细胞的过继转移靶向癌症 miRNA
- 批准号:
8893915 - 财政年份:2014
- 资助金额:
$ 35.57万 - 项目类别: